{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:01:04Z","timestamp":1792512064915,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>To study the effect of follicle sizes of different proportions on oocyte and embryo quality in young and advanced-age patients, and provide evidence for personalized protocol adjustment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a retrospective real-world data study including a total of 11,462 patients who had started their first <jats:italic>in vitro<\/jats:italic> fertilization cycle with a gonadotropin-releasing hormone antagonist (GnRH-ant) protocol during 2018\u20132021. We classified patients into groups according to the size of the dominant proportion of follicles on the human chorionic gonadotropin (hCG) trigger day: Large, Medium, Small, and Equal (containing equivalent proportions of all three size categories). The Cochran\u2013Mantel\u2013Haenszel test by different Anti-Mullerian Hormone (AMH) and antral follicle count (AFC) was used to compare factors such as the metaphase II (MII) oocyte rate, normal fertilization rate, and two pronuclei (2PN) cleavage rate between groups. General linear model (GLM) analysis was performed for inter-group comparison of the oocyte and embryo quality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In patients aged &amp;lt; 35 years and with AMH \u2265 1.2\u03bcg\/L, the MII oocyte percentages in the Large and Medium groups were significantly higher than in the Small group (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). The germinal vesicle (GV) oocyte and unavailable oocyte percentages in the Large and Medium groups were lower than in the Small group (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Among patients aged \u2265 35 years with AFC &amp;lt; 5 and AMH \u2265 1.2\u03bcg\/L, the GV oocyte percentage in the Large group was significantly lower than in the Medium group (2.54% vs. 4.46%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). In patients &amp;lt; 35 years, the GLM demonstrated that the Large and Medium groups had positively impacted on the development of MII oocyte and live birth rate(LBR) of first embryo transfer(ET)(\u03b2&amp;gt;0, all <jats:italic>P<\/jats:italic> value &amp;lt; 0.05);and had less likely to develop into unavailable oocyte, degenerated oocyte, GV oocyte and MI oocyte rates relative to the Small group(\u03b2&amp;lt;0, all <jats:italic>P<\/jats:italic> value &amp;lt; 0.05). And among patients \u2265 35 years, the Medium group had positively impacted on the development of MII oocyte and 2PN rates relative to the Small group(\u03b2&amp;gt;0, all <jats:italic>P<\/jats:italic> value &amp;lt; 0.05); and had less likely to develop into MI oocytes relative to the Small group(\u03b2&amp;lt;0, all <jats:italic>P<\/jats:italic> value &amp;lt; 0.05). The GLM indicated that AMH, along with Gn total dose, start dose, and Gn days, had significant impact on oocyte and embryo quality. For young patients, age was not a significant influencing factor, but for advanced-age patients, age influenced the outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our analysis suggests that for young patients (&amp;lt; 35 years), triggering when there is a high proportion of large or medium follicles results in better quality oocytes, while for older patients (\u2265 35 years), it is better to trigger when the proportion of medium follicles is no less than that of small follicles. Further research is required to confirm these findings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1167395","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:32:46Z","timestamp":1681450366000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of follicular size categories on oocyte quality at trigger day in young and advanced-age patients undergoing GnRH-ant therapy"],"prefix":"10.3389","volume":"14","author":[{"given":"Jingwei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-018-1304-4","article-title":"Paternal factors contributing to embryo quality","volume":"35","author":"Colaco","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmm040","article-title":"Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality","volume":"14","author":"Gilchrist","year":"2008","journal-title":"Hum Reprod Update"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.10.026","article-title":"Optimal lead follicle size for human chorionic gonadotropin trigger in clomiphene citrate and intrauterine insemination cycles: an analysis of 1,676 treatment cycles","volume":"115","author":"Hancock","year":"2021","journal-title":"Fertil Steril"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18955","article-title":"Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval","volume":"51","author":"Wirleitner","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-012-9919-3","article-title":"Comparing the efficacy of urinary and recombinant hCG on oocyte\/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial","volume":"30","author":"Madani","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.fertnstert.2014.03.015","article-title":"Clinical success of intrauterine insemination cycles is affected by the sperm preparation time","volume":"101","author":"Fauque","year":"2014","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg066","article-title":"Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in world health organization type i and type II anovulation","volume":"18","author":"Loumaye","year":"2003","journal-title":"Hum Reprod"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00193","article-title":"Follicle size on day of trigger most likely to yield a mature oocyte","volume":"9","author":"Abbara","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-013-0124-9","article-title":"Correlation between follicular diameters and flushing versus no flushing on oocyte maturity, fertilization rate and embryo quality","volume":"31","author":"Mehri","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.02.011","article-title":"A quantitative assessment of follicle size on oocyte developmental competence","volume":"90","author":"Rosen","year":"2008","journal-title":"Fertil Steril"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-12-107","article-title":"A critical review of bi-dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome","volume":"12","author":"Revelli","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/rmb2.12382","article-title":"Relationship between follicular size and developmental capacity of oocytes under controlled ovarian hyperstimulation in assisted reproductive technologies","volume":"20","author":"Tamura","year":"2021","journal-title":"Reprod Med Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1023\/a:1022977002954","article-title":"Correlation between human follicular diameter and oocyte outcomes in an ICSI program","volume":"20","author":"Triwitayakorn","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"B14","first-page":"397","article-title":"Association among diameter and volume of follicles, oocyte maturity, and competence in intracytoplasmic sperm injection cycles","volume":"67","author":"Akbariasbagh","year":"2015","journal-title":"Minerva Ginecol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deac114","article-title":"Ovulation triggering with hCG alone, GnRH agonist alone or in combination? a randomized controlled trial in advanced-age women undergoing IVF\/ICSI cycles","volume":"37","author":"Zhou","year":"2022","journal-title":"Hum Reprod"},{"key":"B16","doi-asserted-by":"publisher","first-page":"16401","DOI":"10.1038\/s41598-022-20619-4","article-title":"GnRH agonist-triggering ovulation in women with advanced age","volume":"12","author":"Rahav Koren","year":"2022","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12958-021-00814-0","article-title":"Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from china","volume":"19","author":"Yang","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn101441-20211108-00495","article-title":"Expert consensus on the standardized application of GnRH-ant protocol in assisted reproduction technology","volume":"42","author":"Li","year":"2022","journal-title":"Chin J Reprod Contracep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1004-3845.2018.10.003","article-title":"Chinese expert consensus on numbers of embryos transferred","volume":"27","author":"Sun","year":"2018","journal-title":"J Reprod Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/1471-0528.15942","article-title":"Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: AGAINST: Pre-implantation genetic screening should not be used in all IVF cycles in women over the age of 35 years","volume":"126","author":"Ledger","year":"2019","journal-title":"BJOG"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa070","article-title":"POSEIDON classification and the proposed treatment options for groups 1 and 2: time to revisit? a retrospective analysis of 1425 ART cycles","volume":"2021","author":"Chinta","year":"2021","journal-title":"Hum Reprod Open"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.02.017","article-title":"The effect of ovarian follicle size on oocyte and embryology outcomes","volume":"117","author":"Shapiro","year":"2022","journal-title":"Fertil Steril"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.10.003","article-title":"Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis","volume":"87","author":"Kosmas","year":"2007","journal-title":"Fertil Steril"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3109\/09513591003686312","article-title":"The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients","volume":"26","author":"Farhi","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.7.1901","article-title":"The relationship between follicular fluid aspirate volume and oocyte maturity in in-vitro fertilization cycles","volume":"13","author":"Salha","year":"1998","journal-title":"Hum Reprod"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.7.1912","article-title":"Comparison of fertilization, cleavage and pregnancy rates of oocytes from large and small follicles","volume":"13","author":"Bergh","year":"1998","journal-title":"Hum Reprod"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.02.005","article-title":"The association between follicle size and oocyte development as a function of final follicular maturation triggering","volume":"40","author":"Mohr-Sasson","year":"2020","journal-title":"Reprod BioMedicine Online"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.08.033","article-title":"Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments","volume":"85","author":"Nogueira","year":"2006","journal-title":"Fertil Steril"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2022.11.003","article-title":"Optimal lead follicle size in letrozole human menopausal gonadotrophin intrauterine insemination cycles with and without spontaneous LH surge","volume":"46","author":"Chen","year":"2022","journal-title":"Reprod BioMed Online"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000510876","article-title":"Does a large (>24 mm) follicle yield a competent Oocyte\/Embryo","volume":"85","author":"Orvieto","year":"2020","journal-title":"Gynecol Obstet Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.domaniend.2020.106485","article-title":"Molecular characteristics of oocytes and somatic cells of follicles at different sizes that influence in vitro oocyte maturation and embryo production","volume":"74","author":"Bezerra","year":"2021","journal-title":"Domest Anim Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez186","article-title":"Oocyte matched follicular fluid anti-mullerian hormone is an excellent predictor of live birth after fresh single embryo transfer","volume":"34","author":"Ciepiela","year":"2019","journal-title":"Hum Reprod"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030859","article-title":"Women in advanced reproductive age: Are the follicular output rate, the follicle-oocyte index and the ovarian sensitivity index predictors of live birth in an IVF cycle","volume":"11","author":"Carosso","year":"2022","journal-title":"J Clin Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00589","article-title":"Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-the follicle-To-Oocyte (FOI) index","volume":"9","author":"Alviggi","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2018.01.008","article-title":"Poor ovarian response as a predictor for live birth in older women undergoing IVF","volume":"36","author":"Cohen","year":"2018","journal-title":"Reprod BioMed Online"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.617704","article-title":"In vitro follicular activation and stem cell therapy as a novel treatment strategies in diminished ovarian reserve and primary ovarian insufficiency","volume":"11","author":"F\u00e0bregues","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep276","article-title":"Anti-mullerian hormone and inhibin b levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus","volume":"24","author":"Soto","year":"2009","journal-title":"Hum Reprod"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep210","article-title":"Anti-mullerian hormone (AMH): what do we still need to know","volume":"24","author":"La Marca","year":"2009","journal-title":"Hum Reprod"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00094","article-title":"Advanced maternal age in IVF: Still a challenge? the present and the future of its treatment","volume":"10","author":"Ubaldi","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx026","article-title":"Human female meiosis revised: new insights into the mechanisms of chromosome segregation and aneuploidies from advanced genomics and time-lapse imaging","volume":"23","author":"Capalbo","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B41","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s13023-022-02594-1","article-title":"Trends in the prevalence, prenatal diagnosis, and outcomes of births with chromosomal abnormalities: a hospital-based study in zhejiang province, china during 2014-2020","volume":"17","author":"Chen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2020.108320","article-title":"Mechanisms of oocyte aneuploidy associated with advanced maternal age","volume":"785","author":"Mikwar","year":"2020","journal-title":"Mutat Res Rev Mutat Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1167395\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:32:53Z","timestamp":1681450373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1167395\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":42,"alternative-id":["10.3389\/fendo.2023.1167395"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1167395","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"article-number":"1167395"}}